Literature DB >> 9602677

Decentralised anticoagulant care.

T Baglin.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9602677      PMCID: PMC500497          DOI: 10.1136/jcp.51.2.89

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

1.  Audit of anticoagulant therapy.

Authors:  P E Rose
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

2.  Monitoring oral anticoagulation in primary care.

Authors:  D A Fitzmaurice; F D Hobbs; J A Murray
Journal:  BMJ       Date:  1996-06-08

3.  Reliability of delayed INR determination: implications for decentralized anticoagulant care with off-site blood sampling.

Authors:  T Baglin; R Luddington
Journal:  Br J Haematol       Date:  1997-03       Impact factor: 6.998

4.  Methods for managing the increased workload in anticoagulant clinics.

Authors:  F C Taylor; M E Ramsay; A Renton; H Cohen
Journal:  BMJ       Date:  1996-02-03

5.  Introduction of computer assisted control of oral anticoagulation in general practice.

Authors:  M J Galloway; J J Foggin; S Dixon
Journal:  J Clin Pathol       Date:  1995-12       Impact factor: 3.411

6.  Evaluation of computerized decision support for oral anticoagulation management based in primary care.

Authors:  D A Fitzmaurice; F D Hobbs; E T Murray; C P Bradley; R Holder
Journal:  Br J Gen Pract       Date:  1996-09       Impact factor: 5.386

7.  Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.

Authors:  J P Pell; B McIver; P Stuart; D N Malone; J Alcock
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

  7 in total
  2 in total

1.  Decentralised anticoagulant care.

Authors:  D A Fitzmaurice; E T Murray; F D Hobbs
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

2.  Evaluation of an alternative model of anticoagulant care.

Authors:  B J Hennessy; M Vyas; B Duncan; S A Allard
Journal:  Ir J Med Sci       Date:  2000 Jan-Mar       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.